---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033579"
form_type: "8-K"
ticker: "CLDI"
cik: "0001855485"
company_name: "Calidi Biotherapeutics, Inc."
filed_at: "2024-08-22T23:59:59+00:00"
generated_at: "2026-05-31T08:07:18.588095+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Calidi Biotherapeutics posts presentation on new wholly owned subsidiary Redtail Biopharma

## Summary
- Presentation made available August 22, 2024 on company website.
- Redtail Biopharma, Inc. is a new wholly owned subsidiary of Calidi Biotherapeutics.
- No financial terms or strategic details disclosed in the 8-K or presentation excerpt.

## SEC filing metadata
- accession: 0001493152-24-033579
- form_type: 8-K
- ticker: CLDI
- cik: 0001855485
- company_name: Calidi Biotherapeutics, Inc.
- filed_at: 2024-08-22T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1855485/000149315224033579/0001493152-24-033579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1855485/000149315224033579/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033579
- JSON: https://secwatch.observer/filing/0001493152-24-033579.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033579.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.